Content area
We present a hydrogen/deuterium exchange workflow coupled to tandem mass spectrometry (HX-MS2) that supports the acquisition of peptide fragment ions alongside their peptide precursors. The approach enables true auto-curation of HX data by mining a rich set of deuterated fragments, generated by collisional-induced dissociation (CID), to simultaneously confirm the peptide ID and authenticate MS1-based deuteration calculations. The high redundancy provided by the fragments supports a confidence assessment of deuterium calculations using a combinatorial strategy. The approach requires data-independent acquisition (DIA) methods that are available on most MS platforms, making the switch to HX-MS2 straightforward. Importantly, we find that HX-DIA enables a proteomics-grade approach and wide-spread applications. Considerable time is saved through auto-curation and complex samples can now be characterized and at higher throughput. We illustrate these advantages in a drug binding analysis of the ultra-large protein kinase DNA-PKcs, isolated directly from mammalian cells.
Manual data mining for HDX-MS restricts the use of this biophysical technique to a small number of samples run by specialty labs. Enabled by data-independent acquisition methodology, the authors describe an approach that fully automates and standardizes the information extraction process, opening the door to new and challenging applications.
Details
Mass spectrometry;
Fragments;
Mathematical analysis;
Proteomics;
Combinatorial analysis;
Information retrieval;
Mammalian cells;
Workflow;
Peptides;
Scientific imaging;
Automation;
Data mining;
Kinases;
DNA-dependent protein kinase;
Redundancy;
Hydrogen-deuterium exchange;
Data processing;
Data analysis;
Deuteration;
Protein kinase C;
Mass spectroscopy;
Information processing;
Hydrogen
; Syed, Aleem 5
; Tainer, John A. 6 ; Lees-Miller, Susan P. 1
; Schriemer, David C. 2
1 University of Calgary, Department of Biochemistry and Molecular Biology, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
2 University of Calgary, Department of Biochemistry and Molecular Biology, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Chemistry, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
3 Trajan Scientific & Medical - Raleigh, Morrisville, USA (GRID:grid.22072.35)
4 Thermo Fisher Scientific, San Jose, USA (GRID:grid.418190.5) (ISNI:0000 0001 2187 0556)
5 Dana-Farber Cancer Institute, Harvard Medical School, Division of Radiation and Genome Instability, Department of Radiation Oncology, Boston, USA (GRID:grid.65499.37) (ISNI:0000 0001 2106 9910)
6 The University of Texas MD Anderson Cancer Center, Department of Molecular and Cellular Oncology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776); Lawrence Berkeley National Laboratory, Molecular Biophysics and Integrated Bioimaging, Berkeley, USA (GRID:grid.184769.5) (ISNI:0000 0001 2231 4551)